GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended March 31, 2009. For the first quarter, sales at Rs. 5,39,37 Lacs were up by 31.3 %, with PBT growing by 53.3 % to Rs. 1,32,37 Lacs and PAT growing by 48.4 % to Rs. 83,89 Lacs.

In its Golden Jubilee year, the Company also declared final dividend @ Rs.5.00 per equity share of Rs.10 each for the year ended 31 December 2008.

The year 2009 started with the introduction of HORLICKS NUTRIBAR, a nutritional snack for health conscious people. The product has been very well received by consumers. alike and the initial off-take reports are extremely encouraging. Soon thereafter ActiGrow, a high protein content baby food, was also launched during the quarter. This marks a very good beginning to what promises to be an action packed year of new product introductions.

Riding the 2009 IPL fever, Boost tied-up with Rajasthan Royals as its "official energy drink" partner.

GSKCH is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people.

GSKCH has a strong marketing and distribution network in India comprising over 1,000 wholesalers and direct coverage of over 3,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.